Home / PDA Letters (Cards)

PDA Letters (Cards)

Future Challenges in Visual Inspection Processes

John Shabushnig, PhD, Insight Pharma Consulting, and Markus Lankers, PhD, Mibic GmbH

Big Data, Pharma 4.0 and Legacy Products

Jana Spes, Boston Biomedical, and Wayne Levin, Predictum

Big Data: The Panacea for Pharma’s Ills?

Khan Lau, Promedica International

Build Your CCI Knowledge Base Through Data, Tech

Jaime Cobo, WILCO AG

Meet the PDA Letter’s First Intern

Aneeta Mathur-Ashton, American University

Hot Read: GMP in Practice

Rebecca Stauffer, PDA

Exciting New Changes are Coming to Pharma

Melissa Seymour, Biogen, Inc., and Ghada Haddad , Merck & Co./ Merck Sharp & Dohme

Pharmacy Student Sees Future of Pharma in Berlin

Aoife Clancy, Trinity College Dublin

Risk-Benefit Analysis More of NCA Scope

Rebecca Stauffer, PDA

New Perspectives on Freeze-Drying

Thomas Beutler, GEA, and Yves Mayeresse, GSK

Southeast Chapter Meeting Pairs Wine, Decon Tech

John Groth, SKAN US

Standing Guard

John Dubczak, Charles River Laboratories

Endotoxin Testing Using Recombinant Reagents

Karolina Heed, Hyglos - a bioMérieux company

A Deep Dive into Pharmacopeial Harmonization

Rebecca Stauffer, PDA

Deep Learning in the Information Swamp

Heino Prinz, Rommelag

Does QRM + RMM = Better EM?

Dalmaso Gilberto, PhD, and Lisa G. Lawson, Particle Measuring Systems

Going Beyond Patient Preference

Nic Bowman, Pfizer

Build Connections at Two PDA Events

Rebecca Stauffer, PDA

New Trends, New Challenges for BET

Jay Bolden, Eli Lilly and Company, and Ned Mozier, PhD, Pfizer

Drug Delivery Combination Products Go “Viral”

Lee Leichter, P/L Biomedical